Cephalosporin resistance in Klebsiella pneumoniae from Nova Scotia, Canada

被引:11
|
作者
Melano, Roberto G.
Davidson, Ross J.
Musgrave, Heather L.
Forward, Kevin R. [1 ]
机构
[1] Queen Elizabeth 2 Hlth Sci Ctr, Dept Pathol & Lab Med, Halifax, NS B3H 1V8, Canada
[2] Dalhousie Univ, Dept Pathol, Halifax, NS B3H 1V8, Canada
[3] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1V8, Canada
[4] Dalhousie Univ, Dept Med, Halifax, NS B3H 1V8, Canada
关键词
cephalosporin; Klebsiella pneumoniae; cephalosporin-resistance; amp-C; outer brain protein;
D O I
10.1016/j.diagmicrobio.2006.04.016
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
From 2116 Klebsiella pneumoniae strains isolated between January 2001 and December 2002 in Nova Scotia, Canada, 25 (1.18%) showed a reduced susceptibility to cefoxitin or extended-spectrum cephalosporins. Narrow-spectrum beta-lactamase genes (bla(SHV-II), bla(SHV-I), bla(SHV-26), b/a(SHV-32), bla(SHV-36), and b/a(SHV-40)) were the most prevalent. Four new variants were identified (bla(LEN-17), bla(OKP-B-13), bla(OKP-B-14), and bla(OKP-A-II)), representing the 1st description of bla(OKP) in the Americas. Among the extended-spectrum beta-lactamase (ESBL) genes, bla(SHV-2), bla(SHV2a), bla(SHV-12), and bla(CTX-M-15) were detected (ESBL prevalence of 0.14%). Nineteen strains were resistant to cefoxitin (MIC, 3 2 to > 256 mu g/mL). Nevertheless, an AmpC-like activity was detected in only I strain, which expressed CMY-2. The combined effects of narrow-spectrum beta-lactamase production and decreased or nonexpression of OmpK35/36 porins did not account for the cefoxitin resistance observed in some of these strains. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:197 / 205
页数:9
相关论文
共 50 条
  • [31] Diet quality and cancer incidence in Nova Scotia, Canada
    Fitzgerald, AL
    Dewar, RA
    Veugelers, PJ
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2002, 43 (02): : 127 - 132
  • [32] PERSISTENCE OF DINITRAMINE AND TRIFLURALIN IN NOVA-SCOTIA, CANADA
    JENSEN, KIN
    KIMBALL, ER
    BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY, 1980, 24 (02) : 238 - 243
  • [33] The Incidence and Prevalence of Multiple Sclerosis in Nova Scotia, Canada
    Marrie, Ruth Ann
    Fisk, John D.
    Stadnyk, Karen J.
    Yu, Bo Nancy
    Tremlett, Helen
    Wolfson, Christina
    Warren, Sharon
    Bhan, Virender
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2013, 40 (06) : 824 - 831
  • [34] A comparison of antidepressant use in Nova Scotia, Canada and Australia
    Smith, Alesha J.
    Sketris, Ingrid
    Cooke, Charmaine
    Gardner, David
    Kisely, Steve
    Tett, Susan E.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (07) : 697 - 706
  • [35] Insights from the evaluation of a provincial healthy eating strategy in Nova Scotia, Canada
    Sim, S. Meaghan
    Kirk, Sara F. L.
    PUBLIC HEALTH NUTRITION, 2013, 16 (10) : 1870 - 1878
  • [36] A history of cleavage and folding: an example from the Goldenville Formation, Nova Scotia ( Canada).
    Henderson, J.R.
    Wright, T.O.
    Henderson, M.N.
    Geological Society of America Bulletin, 1986, 97 (11): : 1354 - 1366
  • [37] GIBELLULA-PULCHRA FROM A SPIDER (SALTICIDAE) IN NOVA-SCOTIA, CANADA
    STRONGMAN, DB
    MYCOLOGIA, 1991, 83 (06) : 816 - 817
  • [38] The Pennsylvanian tropical biome reconstructed from the Joggins Formation of Nova Scotia, Canada
    Falcon-Lang, HJ
    Benton, MJ
    Braddy, SJ
    Davies, SJ
    JOURNAL OF THE GEOLOGICAL SOCIETY, 2006, 163 : 561 - 576
  • [39] Build-up of resistance to triadimefon for isolates of Erysiphe graminis f sp tritici from Nova Scotia, Canada
    AlMughrabi, KI
    Gray, AB
    CANADIAN PLANT DISEASE SURVEY, 1996, 76 (01): : 9 - 14
  • [40] THE US CANADA CONVERGENCE THESIS - CONTRARY EVIDENCE FROM NOVA-SCOTIA
    GILSON, CHJ
    WAGAR, T
    RELATIONS INDUSTRIELLES-INDUSTRIAL RELATIONS, 1995, 50 (01): : 66 - 84